Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
stevepb / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease
mohamed_hassan / Pixabay

Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

According to a publication from the Rheumatologist, past studies have suggested that type 1 interferons may play a significant role in determining susceptibility to several classic connective tissue diseases. Although…

Continue Reading Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

Otezla Receives FDA Approval for Treatment of Oral Sores that Characterize Behçet’s Disease

According to a press release from American biotechnology company Celgene Corporation, the American Food and Drug Administration (FDA) recently approved the Company's drug Otezla (generic name apremilast) for the treatment…

Continue Reading Otezla Receives FDA Approval for Treatment of Oral Sores that Characterize Behçet’s Disease

New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

The most common treatment for autoimmune conditions such as ankylosing spondylitis, plaque psoriasis, Crohn's disease, juvenile idiopathic arthritis, and rheumatoid arthritis is currently a drug called Humira, created by AbbVie.…

Continue Reading New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients
This Drug Could Treat Psoriatic Arthritis and Ankylosing Spondylitis
12019 / Pixabay

This Drug Could Treat Psoriatic Arthritis and Ankylosing Spondylitis

According to a story from globenewswire.com, Galapagos NV and Gilead Sciences, Inc., recently announced that two clinical trials which were recently published in The Lancet demonstrated that the experimental treatment filgotinib could…

Continue Reading This Drug Could Treat Psoriatic Arthritis and Ankylosing Spondylitis
Four New Drugs Accepted by the Scottish Medicines Consortium
qimono / Pixabay

Four New Drugs Accepted by the Scottish Medicines Consortium

The Scottish Medicines Consortium, a committee that advises NHS Scotland on what medicines they should provide, has accepted four new drugs for use. These are gemtuzumab ozogamicin for acute myeloid…

Continue Reading Four New Drugs Accepted by the Scottish Medicines Consortium
Let’s Come Together for World Autoimmune Arthritis Day!
Source: Pixabay

Let’s Come Together for World Autoimmune Arthritis Day!

Sunday, May 20th is World Autoimmune Arthritis Day! The global awareness day is aimed at raising money, consciousness, and solidarity for the millions of people who suffer from one of many arthritic…

Continue Reading Let’s Come Together for World Autoimmune Arthritis Day!
Study Shows Female Psoriatic Arthritis Patients Have Higher Rates of Psychiatric Disorders
source: pixabay.com

Study Shows Female Psoriatic Arthritis Patients Have Higher Rates of Psychiatric Disorders

In data presented earlier this month in San Diego at the 2017 American College of Rheumatology Annual Meeting, researchers noted that female patients with psoriatic arthritis had significantly higher rates of…

Continue Reading Study Shows Female Psoriatic Arthritis Patients Have Higher Rates of Psychiatric Disorders
TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says
Source: pixabay.com

TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says

According to an article from Righting Injustice, a recent study suggests that TNF inhibitors may increase the risk of rare cancers in pediatric patients. The study recommends that children that…

Continue Reading TNF Inhibitors May Put Children at Risk For Rare Cancers, Study Says